Interleukin-27: balancing protective and pathological immunity
about
Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseasesNK-DC crosstalk controls the autopathogenic Th17 response through an innate IFN-γ-IL-27 axis.Anti-Inflammatory Effects of IL-27 in Zymosan-Induced Peritonitis: Inhibition of Neutrophil Recruitment Partially Explained by Impaired Mobilization from Bone Marrow and Reduced Chemokine LevelsExpanding Diversity in Molecular Structures and Functions of the IL-6/IL-12 Heterodimeric Cytokine FamilyIL-27R signaling controls myeloid cells accumulation and antigen-presentation in atherosclerosis.Interleukin 27 inhibits cytotoxic T-lymphocyte-mediated platelet destruction in primary immune thrombocytopenia.The Severity of Visceral Leishmaniasis Correlates with Elevated Levels of Serum IL-6, IL-27 and sCD14.Common Polymorphisms in IL-27 Genes May Contribute to Risk of Various Human Diseases in Asian Populations: A Meta-Analysis.Interleukin-27 is differentially associated with HIV viral load and CD4+ T cell counts in therapy-naïve HIV-mono-infected and HIV/HCV-co-infected ChineseWhole-genome sequencing of individuals from a founder population identifies candidate genes for asthmaMyocardial gene expression of T-bet, GATA-3, Ror-γt, FoxP3, and hallmark cytokines in chronic Chagas disease cardiomyopathy: an essentially unopposed TH1-type response.STAT4 deficiency fails to induce lung Th2 or Th17 immunity following primary or secondary respiratory syncytial virus (RSV) challenge but enhances the lung RSV-specific CD8+ T cell immune response to secondary challenge.Expression of IL-27 by tumor cells in invasive cutaneous and metastatic melanomas [corrected]..Effects of statins on TH1 modulating cytokines in human subjects.Canonical wnt signaling in dendritic cells regulates Th1/Th17 responses and suppresses autoimmune neuroinflammation.Intravenous administration of bone marrow-derived mesenchymal stem cells induces a switch from classical to atypical symptoms in experimental autoimmune encephalomyelitis.Polymorphisms and plasma levels of IL-27: impact on genetic susceptibility and clinical outcome of bladder cancer.IL-27 Signaling Is Crucial for Survival of Mice Infected with African Trypanosomes via Preventing Lethal Effects of CD4+ T Cells and IFN-γ.Epstein-Barr virus-induced gene 3-deficiency leads to impaired antitumor T-cell responses and accelerated tumor growth.Blimp-1-Dependent IL-10 Production by Tr1 Cells Regulates TNF-Mediated Tissue Pathology.Interleukin 27R regulates CD4+ T cell phenotype and impacts protective immunity during Mycobacterium tuberculosis infection.Interleukin 35: Critical regulator of immunity and lymphocyte-mediated diseases.IL-27 Limits Type 2 Immunopathology Following Parainfluenza Virus Infection.T Cell Vaccinology: Beyond the Reflection of Infectious ResponsesDouble-Negative αβ T Cells Are Early Responders to AKI and Are Found in Human KidneyIL-Y, a synthetic member of the IL-12 cytokine family, suppresses the development of type 1 diabetes in NOD miceIL-27 Promotes Proliferation of Human Leukemic Cell Lines Through the MAPK/ERK Signaling Pathway and Suppresses Sensitivity to Chemotherapeutic Drugs.IL-27 Induced by Select Candida spp. via TLR7/NOD2 Signaling and IFN-β Production Inhibits Fungal Clearance.Cytokine and chemokine responses to helminth and protozoan parasites and to fungus and mite allergens in neonates, children, adults, and the elderly.Type 1 diabetes genetic susceptibility and dendritic cell function: potential targets for treatment.The role of IL-27 in the induction of anti-tumor cytotoxic T lymphocyte responseCD4+ T cells are trigger and target of the glucocorticoid response that prevents lethal immunopathology in toxoplasma infectionModulation of inflammation by interleukin-27.Activation of IL-27 signalling promotes development of postinfluenza pneumococcal pneumonia.IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39.Adenovirus serotype 5 vaccine vectors trigger IL-27-dependent inhibitory CD4+ T cell responses that impair CD8+ T cell function.Attenuation of intestinal inflammation in interleukin-10-deficient mice infected with Citrobacter rodentium.Interleukin 35: a key mediator of suppression and the propagation of infectious tolerance.Modeling the T cell immune response: a fascinating challenge.Mutant p53 in concert with an interleukin-27 receptor alpha deficiency causes spontaneous liver inflammation, fibrosis, and steatosis in mice
P2860
Q26775111-E7A92887-232F-4FA3-8CB6-5E63B4B28051Q27308853-60660C2B-40A8-4CCE-B39D-DA3F37C54918Q27318494-765ACBDA-4C5C-48AE-98BD-D4EDA71412B5Q28075849-861F4A71-89F6-4029-8C2C-94FF6AC4B1E4Q30852948-4F00CC06-5C7F-4F4A-8315-7FCF285442C6Q33418068-64B4A57A-9871-4BA4-A2CC-68DE72EA5CE3Q33429539-AE6725BF-EFC2-4CFD-9D8A-1AA8CCDDED8DQ33430535-824DD306-4C7D-4BDC-BD79-07704FFDA8FBQ33590441-78063625-6F6B-4EE0-9CCB-02B33975DC10Q34035181-1DC7D2F2-2FFB-4C20-8AC8-E9EAC6A92EA4Q34053139-103AD2A7-9C83-46F0-B2CD-127FB1BCF703Q34059593-B2DB2E0E-1188-4CCC-8D8F-7BD63A7097DEQ35018373-8305B5D7-8013-45D9-87B7-85628D111DE9Q35081825-B799E0C7-7901-4B16-8686-0D2B0ED26507Q35205455-85F5201E-2A4A-44F0-9D2C-9BE7AACA1333Q35206941-3EDE723C-9D83-4665-9ABC-416BB977F221Q35654119-1BCE56E1-8423-4058-93DC-1A5DC7E5C206Q35722876-553E7D8A-32A4-4223-80FB-D02C298A5AB7Q35799014-10ECC73C-74E9-4785-BF82-2EC0DBE6BEE7Q35893711-A47D266F-F8C0-4317-B922-AF783CC820E5Q35992186-334C47E1-F1E4-4FCD-A273-3F6B9B0BD1AFQ36090326-73AF70BD-7837-4D89-AB82-40BDB2935EFEQ36262581-C3B1CAFD-7F31-4EA3-9359-EA59056FEF9DQ36642440-13024E0B-1D43-4A28-A790-14EE6ECB3DFCQ36746046-6B555377-3753-4939-B4A4-2EF1A8696EA3Q36774544-8148FB33-A99F-43E7-AAA2-1ED29C0297CCQ36861764-77DB1A67-5824-486F-91D0-8EE66D767B54Q37015050-56553726-226A-45CF-8BF4-D4EDA866CE4BQ37038054-E9888EBB-176D-4F8E-B9CE-0AF76DA8D7BDQ37098079-AE42574F-BFAF-4921-953C-F8A8BF31A21CQ37099883-35DE4A52-F781-41F6-A6D8-0DE3F9EA0579Q37194971-A233297B-A515-4BA9-9233-1C4AD887BEEFQ37309924-2B9E80C2-B8A2-4881-998B-54E8C51D3358Q37606436-259EA025-94B3-466B-A875-058E98A1921CQ37659617-5FB38769-0660-4D7C-99A5-44B54400AB22Q37661779-5214F44A-1650-47F6-8988-749D99486903Q37713389-8222CAEF-3903-4EB9-A134-BB424EC30D52Q38154886-2F6EEBA5-F64C-4F81-AFCF-B8220053DE88Q38243170-770A9B31-436E-4094-A9BF-82ADFF0BBB16Q38603775-F761484F-EC7C-4E82-B70A-9B913F72575B
P2860
Interleukin-27: balancing protective and pathological immunity
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Interleukin-27: balancing protective and pathological immunity
@ast
Interleukin-27: balancing protective and pathological immunity
@en
Interleukin-27: balancing protective and pathological immunity
@nl
type
label
Interleukin-27: balancing protective and pathological immunity
@ast
Interleukin-27: balancing protective and pathological immunity
@en
Interleukin-27: balancing protective and pathological immunity
@nl
prefLabel
Interleukin-27: balancing protective and pathological immunity
@ast
Interleukin-27: balancing protective and pathological immunity
@en
Interleukin-27: balancing protective and pathological immunity
@nl
P2860
P3181
P1433
P1476
Interleukin-27: balancing protective and pathological immunity
@en
P2093
Christopher A. Hunter
Rob Kastelein
P2860
P3181
P356
10.1016/J.IMMUNI.2012.11.003
P407
P577
2012-12-14T00:00:00Z